These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14493137)

  • 1. A comparison of laboratory methods for the control of anticoagulant therapy with prothrombinopenic agents. I. The Quick one-stage procedure, the prothrombin and proconvertin test and the one-stage determination of true prothrombin activity.
    RODMAN T; PASTOR BH; FAWCETT KC
    Am J Med; 1961 Oct; 31():547-54. PubMed ID: 14493137
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of laboratory methods for the control of anticoagulant therapy with prothrombinopenic agents. II. Problems encountered in the laboratory control of anticoagulant therapy with one-stage determination of prothrombin complex activity.
    RODMAN T; PASTOR BH; HOXTER BL
    Am J Med; 1961 Oct; 31():555-63. PubMed ID: 14493138
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 4. [Owren's method for quantitative prothrombin-proconvertin determination in control of anticoagulant therapy].
    LUND E
    Ugeskr Laeger; 1953 May; 115(21):801-5. PubMed ID: 13077997
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of coagulation time obtained with the one-stage method according to Quick (prothrombin time) and according to Owren (prothrombin-proconvertin time) in the control of coumarin treatment].
    CLETON FJ
    Ned Tijdschr Geneeskd; 1959 Sep; 103():1835-6. PubMed ID: 13810671
    [No Abstract]   [Full Text] [Related]  

  • 6. LABORATORY STUDIES ON PATIENTS RECEIVING ANTICOAGULANT THERAPY.
    SHAW S; PEGRUM GD; WOLFF S
    J Clin Pathol; 1965 May; 18(3):327-9. PubMed ID: 14304246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analytical study on Quick test; determination of prothrombin, proconvertin, and proaccelerin].
    SOULIER JP; LARRIEU MJ
    Sang; 1952; 23(7):549-59. PubMed ID: 13004906
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 9. [The hirudin test, a micromethod for control of the prothrombin level in anticoagulant therapy].
    SCHMUTZLER R; MARKWARDT F
    Klin Wochenschr; 1962 Aug; 40():796-8. PubMed ID: 13908867
    [No Abstract]   [Full Text] [Related]  

  • 10. DO BARBITURATES INFLUENCE THE PROTHROMBIN-PROCONVERTIN LEVEL DURING ANTICOAGULANT THERAPY?
    SAMUELSSON SM; LILIENBERG G
    Scand J Clin Lab Invest; 1965; 17():73-9. PubMed ID: 14260757
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 12. [Our experience on the control of anticoagulant therapy with special reference to the proconvertin-prothrombin method].
    ESPINOS PEREZ D
    Rev Clin Esp; 1959 Aug; 74():147-54. PubMed ID: 13820807
    [No Abstract]   [Full Text] [Related]  

  • 13. SELF THROMBOPLASTIN-PROTHROMBIN TIME. A NEW TEST IN HEMORRHAGIC SYNDROMES AND IN THE CONTROL OF ANTICOAGULANT THERAPY.
    BERKARDA B; DERMAN U
    Thromb Diath Haemorrh; 1964 Jul; 11():468-75. PubMed ID: 14191724
    [No Abstract]   [Full Text] [Related]  

  • 14. [EVALUATION OF METHODS FOR THE DETERMINATION OF THE PROTHROMBIN COMPLEX ACTIVITY].
    MARES J; PODLIPNY J
    Z Arztl Fortbild (Jena); 1964 Jun; 58():709-13. PubMed ID: 14240434
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of two laboratory tests in the control of anticoagulant therapy.
    Pearce SJ; Sekar AS
    J Clin Pathol; 1973 Jan; 26(1):73-6. PubMed ID: 4693900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IMPORTANCE OF THE THROMBOTEST. II. A COMPARATIVE STUDY OF THE THROMBOTEST, THROMBOPLASTIN TIME AND PARTIAL THROMBOPLASTIN TIME].
    FREDERIKS PW
    Ned Tijdschr Geneeskd; 1964 Jan; 108():156-61. PubMed ID: 14135805
    [No Abstract]   [Full Text] [Related]  

  • 17. OMEPHINE, A NEW ANTICOAGULANT.
    KOPTELOVA MN
    Fed Proc Transl Suppl; 1963; 22():1256-8. PubMed ID: 14079350
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of the relationship of concentrations of prothrombin, proconvertin, and proaccelerin to three methods for measuring prothrombin time.
    GONYEA LM; HJORT P; OWREN PA
    J Lab Clin Med; 1956 Oct; 48(4):624-33. PubMed ID: 13367602
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anticoagulant therapy. Use in a new prothrombin activity range].
    de ALMEIDA E; GINEFRA P; MONTEIRO MM; RIBEIRO CP; de ALMEIDA A
    Rev Bras Oftalmol; 1960 Dec; 17():1024-33. PubMed ID: 13860659
    [No Abstract]   [Full Text] [Related]  

  • 20. THROMBOPLASTIC ACTIVITY OF HUMAN SALIVA IN PATIENTS UNDER PROLONGED ANTICOAGULATION THERAPY.
    DOKU HC; TAYLOR RG; SISE HS; BECKER R
    J Dent Res; 1964; 43():323-30. PubMed ID: 14159035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.